---
layout: post
title: "大摩：看低ADG106成功率 下调天演药业(ADAG.US)目标价至15美元"
date: 2022-02-01 21:40:42 +0800
categories: zhitongcaijingwang
tags: 智通财经网新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/105.ADAG" data-code="ADAG|105|7" data-code2="ADAG|105|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=105.ADAG&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 ADAG_0" data-code="K ADAG|105|7" data-code2="K ADAG|105|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>摩根士丹利分析师Matthew Harrison将天演药业(ADAG.US)的目标价从27美元下调至15美元，并维持“增持”评级。Harrison表示，已经将ADG106的成功几率从之前的30%-35%降至10%-15%。<br /></p><p class="em_media">（文章来源：智通财经网）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202202012267085233>

[返回智通财经网新闻](//finews.withounder.com/category/zhitongcaijingwang.html)｜[返回首页](//finews.withounder.com/)